Cargando…
A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2
In a recent report, no significance of transglutaminase 2 (TGase 2) was noted in the analyses of expression differences between normal and clear cell renal cell carcinoma (ccRCC), although we found that knock down of TGase 2 induced significant p53-mediated cell death in ccRCC. Generally, to find ef...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177245/ https://www.ncbi.nlm.nih.gov/pubmed/32260198 http://dx.doi.org/10.3390/ijms21072493 |